bristol myers settles pricing probes a wsj news roundup bristol myers squibb co completed a settlement announced in december with the justice department and u s attorneys office in massachusetts in which the company agreed to pay more than &# million the agreement settles federal and state investigations into the new york drug makers marketing and pricing practices government investigators alleged that bristol myers paid illegal remuneration from to in the form of consulting fees to induce doctors and other health care providers to buy the companys drugs they alleged that bristol myers set and maintained fraudulent and inflated prices for an assortment of oncology and generic drug products and knowingly misreported pricing of the antidepressant serzone investigators said that from to the company promoted the sale of abilify an antipsychotic drug for pediatric use and to treat dementia related psychoses neither use is approved by the food and drug administration 
